855 related articles for article (PubMed ID: 23973155)
1. The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial.
Gallelli L; Galasso O; Falcone D; Southworth S; Greco M; Ventura V; Romualdi P; Corigliano A; Terracciano R; Savino R; Gulletta E; Gasparini G; De Sarro G
Osteoarthritis Cartilage; 2013 Sep; 21(9):1400-8. PubMed ID: 23973155
[TBL] [Abstract][Full Text] [Related]
2. Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac.
Alvarez-Soria MA; Largo R; Santillana J; Sánchez-Pernaute O; Calvo E; Hernández M; Egido J; Herrero-Beaumont G
Ann Rheum Dis; 2006 Aug; 65(8):998-1005. PubMed ID: 16476713
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
[TBL] [Abstract][Full Text] [Related]
4. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint.
Park YG; Ha CW; Han CD; Bin SI; Kim HC; Jung YB; Lim HC
J Ethnopharmacol; 2013 Oct; 149(3):816-24. PubMed ID: 23954277
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA
Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
[TBL] [Abstract][Full Text] [Related]
6. Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen.
Whelton A; Lefkowith JL; West CR; Verburg KM
Kidney Int; 2006 Oct; 70(8):1495-502. PubMed ID: 16941030
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
Chan FK; Lanas A; Scheiman J; Berger MF; Nguyen H; Goldstein JL
Lancet; 2010 Jul; 376(9736):173-9. PubMed ID: 20638563
[TBL] [Abstract][Full Text] [Related]
8. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis.
Conaghan PG; Dickson J; Bolten W; Cevc G; Rother M
Rheumatology (Oxford); 2013 Jul; 52(7):1303-12. PubMed ID: 23542612
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease.
Ray WA; Varas-Lorenzo C; Chung CP; Castellsague J; Murray KT; Stein CM; Daugherty JR; Arbogast PG; García-Rodríguez LA
Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):155-63. PubMed ID: 20031832
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib does not affect the release of hyaluronic acid in end stage osteoarthritic joints.
Takahashi D; Majima T; Onodera T; Kasahara Y; Inoue M; Irie T; Kasemura T
Mod Rheumatol; 2013 Sep; 23(5):934-8. PubMed ID: 23001685
[TBL] [Abstract][Full Text] [Related]
11. Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis.
Alvarez-Soria MA; Herrero-Beaumont G; Moreno-Rubio J; Calvo E; Santillana J; Egido J; Largo R
Osteoarthritis Cartilage; 2008 Dec; 16(12):1484-93. PubMed ID: 18547825
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
14. Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib.
Bianchi M; Broggini M; Balzarini P; Franchi S; Sacerdote P
Int J Clin Pract; 2007 Aug; 61(8):1270-7. PubMed ID: 17590218
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.
Schnitzer TJ; Ekman EF; Spierings EL; Greenberg HS; Smith MD; Brown MT; West CR; Verburg KM
Ann Rheum Dis; 2015 Jun; 74(6):1202-11. PubMed ID: 24625625
[TBL] [Abstract][Full Text] [Related]
16. Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study.
Altman RD; Strand V; Hochberg MC; Gibofsky A; Markenson JA; Hopkins WE; Cryer B; Kivitz A; Nezzer J; Imasogie O; Young CL
Postgrad Med; 2015 Jun; 127(5):517-28. PubMed ID: 25913498
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of gait parameters to the effects of anti-inflammatory and opioid treatments in knee osteoarthritis patients.
Boyer KA; Angst MS; Asay J; Giori NJ; Andriacchi TP
J Orthop Res; 2012 Jul; 30(7):1118-24. PubMed ID: 22179861
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4 week study.
Wadsworth LT; Kent JD; Holt RJ
Curr Med Res Opin; 2016; 32(2):241-50. PubMed ID: 26506138
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip.
Luyten FP; Geusens P; Malaise M; De Clerck L; Westhovens R; Raeman F; Vander Mijnsbrugge D; Mathy L; Hauzeur JP; De Keyser F; Van den Bosch F
Ann Rheum Dis; 2007 Jan; 66(1):99-106. PubMed ID: 16815864
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of celecoxib versus naproxen in patients with osteoarthritis of the knee: a randomized, double-blind, double-dummy trial.
Essex MN; Bhadra P; Sands GH
J Int Med Res; 2012; 40(4):1357-70. PubMed ID: 22971487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
